The software sector as a whole demonstrated a deteriorating performance during the fourth quarter, but infrastructure ...

V Rising, the vampire survival game that blends Castlevania with Valheim, details new additions and changes coming in its ...

Needham reiterated CyberArk (CYBR) as its Top Pick citing a resilient Privileged Access Management demand and the Venafi ...

Cybersecurity company Palo Alto Networks, Inc. (PANW) announced Wednesday that it has signed a multi-year partnership with ...

Jefferies believes the recent selloff in shares of Microsoft (MSFT) represents an attractive entry point due to a now “derisked valuation.” The ...

January quarter incremental ARR being “impressively” up 27% year-over-year signals that ARR growth is likely inflecting up and April quarter guidance that was “healthily above consensus ...

Seasonality trends indicate that March could turn bullish, especially now that volatility is subsiding.  Yahoo Finance ...

We recently published a list of 10 Jim Cramer Stocks to Watch This Month. In this article, we are going to take a look at ...

emphasizing the breadth of MZE829’s potential patient base and its differentiation from Vertex’s drug. Guggenheim set a $19 price target, citing value-inflecting data expected over the next year.

Even as the U.S. stock market appeared to be stabilizing on Monday, investors and traders were in the process of weighing an important question regarding the next step to take. Investors "are wrestlin ...

Now, Oklahoma City has seen the third-year player put it all together - a chaos-inflecting defender and controlled chaos scorer. A recipe for success now and as games grow in importance.

According to a note out of Goldman Sachs, its analysts have put a buy rating and improved price target of $17.75 on the ASX 200 share. Based on its current share price of $15.96, this implies ...